Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Identify first generic entrants
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
US Army
Argus Health
McKesson
Fish and Richardson
Queensland Health
US Department of Justice
Moodys
McKinsey
Cerilliant

Generated: January 20, 2018

DrugPatentWatch Database Preview

EPINEPHRINE; LIDOCAINE HYDROCHLORIDE - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for epinephrine; lidocaine hydrochloride and what is the scope of epinephrine; lidocaine hydrochloride freedom to operate?

Epinephrine; lidocaine hydrochloride
is the generic ingredient in nine branded drugs marketed by Carlisle, Belmora Llc, Eastman Kodak, Hospira, West-ward Pharms Int, Abbott, Bel Mar, Dell Labs, Intl Medication, Watson Labs, Pharmaton, Septodont, Dentsply Pharm, Astrazeneca, Fresenius Kabi Usa, Vyteris, Iomed, and Empi, and is included in thirty-one NDAs. There are two patents protecting this compound. Additional information is available in the individual branded drug profile pages.

Epinephrine; lidocaine hydrochloride has eight patent family members in seven countries.

There are nineteen drug master file entries for epinephrine; lidocaine hydrochloride. Eleven suppliers are listed for this compound.
Summary for EPINEPHRINE; LIDOCAINE HYDROCHLORIDE
International Patents:8
US Patents:2
Tradenames:9
Applicants:18
NDAs:31
Drug Master File Entries: 19
Suppliers / Packagers: 11
Clinical Trials: 1,196
Drug Prices:see low prices
DailyMed Link:EPINEPHRINE; LIDOCAINE HYDROCHLORIDE at DailyMed

US Patents and Regulatory Information for EPINEPHRINE; LIDOCAINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Astrazeneca XYLOCAINE W/ EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 010418-006 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fresenius Kabi Usa XYLOCAINE W/ EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 006488-004 Approved Prior to Jan 1, 1982 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 089645-001 Jun 21, 1988 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Watson Labs LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 080377-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Bel Mar LIDOCAINE HYDROCHLORIDE W/ EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 080757-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Pharmaton LIDOCATON epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 084729-001 Aug 17, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 089649-001 Jun 21, 1988 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Fresenius Kabi Usa XYLOCAINE W/ EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 006488-019 Nov 13, 1986 AP RX Yes Yes ➤ Subscribe ➤ Subscribe ➤ Subscribe
Belmora Llc LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 080504-004 Oct 19, 1983 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Hospira LIDOCAINE HYDROCHLORIDE AND EPINEPHRINE epinephrine; lidocaine hydrochloride INJECTABLE;INJECTION 089651-001 Jun 21, 1988 AP RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Expired US Patents for EPINEPHRINE; LIDOCAINE HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Vyteris LIDOSITE TOPICAL SYSTEM KIT epinephrine; lidocaine hydrochloride PATCH;IONTOPHORESIS, TOPICAL 021504-001 May 6, 2004 ➤ Subscribe ➤ Subscribe
Vyteris LIDOSITE TOPICAL SYSTEM KIT epinephrine; lidocaine hydrochloride PATCH;IONTOPHORESIS, TOPICAL 021504-001 May 6, 2004 ➤ Subscribe ➤ Subscribe
Vyteris LIDOSITE TOPICAL SYSTEM KIT epinephrine; lidocaine hydrochloride PATCH;IONTOPHORESIS, TOPICAL 021504-001 May 6, 2004 ➤ Subscribe ➤ Subscribe
Vyteris LIDOSITE TOPICAL SYSTEM KIT epinephrine; lidocaine hydrochloride PATCH;IONTOPHORESIS, TOPICAL 021504-001 May 6, 2004 ➤ Subscribe ➤ Subscribe
Vyteris LIDOSITE TOPICAL SYSTEM KIT epinephrine; lidocaine hydrochloride PATCH;IONTOPHORESIS, TOPICAL 021504-001 May 6, 2004 ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Patents for EPINEPHRINE; LIDOCAINE HYDROCHLORIDE

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Citi
McKinsey
Farmers Insurance
Teva
Baxter
Covington
Merck
Novartis
Moodys

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot